Is T-cell priming required for initiation of pathology in malaria infections?
about
Plasmodium malaria and antimalarial antibodies in the first year of lifeEffect of nutrient deficiencies on in vitro Th1 and Th2 cytokine response of peripheral blood mononuclear cells to Plasmodium falciparum infection.Do maternally acquired antibodies protect infants from malaria infection?Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infectionImmunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malariaOptimal tumor necrosis factor induction by Plasmodium falciparum requires the highly localized release of parasite products.Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function.The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.The effect of daily co-trimoxazole prophylaxis on natural development of antibody-mediated immunity against P. falciparum malaria infection in HIV-exposed uninfected Malawian childrenDoes malaria suffer from lack of memory?Developmental allometry and paediatric malaria.Regulating immunity to malaria.Lymphocyte Perturbations in Malawian Children with Severe and Uncomplicated Malaria.Effect of malaria on HIV/AIDS transmission and progression.Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.Monocyte activation and cytokine production in Malawian children presenting with P. falciparum malariaBlockage of Galectin-receptor Interactions by α-lactose Exacerbates Plasmodium berghei-induced Pulmonary Immunopathology.CTLA-4 positive T cells in contrast to procalcitonin plasma levels discriminate between severe and uncomplicated Plasmodium falciparum malaria in Ghanaian children.Serum IL-4, IL-12 and TNF-alpha in malaria: a comparative study associating cytokine responses with severity of disease from the Coastal Districts of Odisha.Cytokine Profiles in Malawian Children Presenting with Uncomplicated Malaria, Severe Malarial Anemia, and Cerebral Malaria.T-Regulatory Cells and Inflammatory and Inhibitory Cytokines in Malawian Children Residing in an Area of High and an Area of Low Malaria Transmission During Acute Uncomplicated Malaria and in Convalescence.Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria.Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model.The proportion of circulating gammadelta T cells increases after the first week of onset of tularaemia and remains elevated for more than a year.Cytokine profile of Plasmodium falciparum-specific T cells in non-immune malaria patients.Activation by malaria antigens renders mononuclear cells susceptible to HIV infection and re-activates replication of endogenous HIV in cells from HIV-infected adults.Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria.The influence of gammadelta T cells on the CD4+ T cell and antibody response during a primary Plasmodium chabaudi chabaudi infection in mice.Immunology of malaria infections.Differential expression pattern of co-inhibitory molecules on CD4+ T cells in uncomplicated versus complicated malaria.HIV infection has a profound effect on hematological factors but not on electrolyte profile of Malawian adults presenting with uncomplicated malaria and severe malaria
P2860
Q26315542-53C69A63-C5E6-4ED7-B8EF-96321C1A656AQ33981456-6E4F7F41-71EB-4644-BEA7-29C3E09B8FFFQ34176239-111FACB1-A728-4BD1-B57B-0AD28F3E44C2Q34443497-ED8C372F-9CB8-4C84-AA35-DAED85D42A98Q34492813-1DE4980F-5A04-49D9-82D8-CE006CFCAD64Q35011368-F5E08E8A-9A97-4826-B5DF-64535C8B865EQ35019935-9C1B6745-CE3E-4F28-9443-C60CFDE72C1BQ35180114-D5354E77-9ACA-4E0B-ACFB-42953B643875Q35217416-15C07A14-2461-43B0-AEFC-5597C16A0576Q35884250-B40B0826-965C-4776-B71E-F6072DE2E76BQ35903025-DB4FC273-F2FE-4BFB-A59A-8433FEE52BCFQ36378338-DEFA2215-C7D1-44C9-8A1E-0C549FD2FDAFQ36555099-976F627D-31A6-401A-87D8-BC09BA10916FQ36588773-24D0C6F4-49F9-4581-90B0-52E3C09404D1Q36785435-3784C42C-8F66-4DE8-9BF2-EB4C89AF1081Q36851152-6833100F-0AE3-4870-BE7D-33C8B111B2BFQ37198958-95D83572-E03A-4D65-B421-B51BC36CDB1BQ38920193-B5247C4E-AEF0-4AA0-8F48-2124229C5309Q38977362-B6DB0146-B781-485C-8A8C-D51B253EF946Q39209812-00B2C1B6-DA10-428C-B34A-71AF562DA253Q39313247-11B1DE7F-F14E-4F0B-BEC6-8229B4743E6AQ39656323-8C6DA070-8B08-4148-9C97-50C49AF1CDD6Q40065575-4D98754F-C6BB-498F-BB6F-47775AA93632Q43921262-2D76DDDF-CB37-4537-87D3-29A76FB69A33Q44174178-6C5494A6-AB7A-4D50-8CA0-DD7E167B076AQ44740479-159C5E97-77E0-4294-8C36-8D50A6BEE75FQ46586552-1C20B37D-EAE6-4249-826B-0EC3E67BDD41Q47903737-BE9CFD8E-BA44-4E8B-B4D1-285C0A9B7A31Q48023150-59E9E585-C3AC-497B-9B06-3571E5821D43Q52647950-82F537B0-74F7-4571-97FF-65834471CF84Q57483769-4EE4F45F-59C9-458C-9374-3DD1D86904D9
P2860
Is T-cell priming required for initiation of pathology in malaria infections?
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Is T-cell priming required for initiation of pathology in malaria infections?
@ast
Is T-cell priming required for initiation of pathology in malaria infections?
@en
type
label
Is T-cell priming required for initiation of pathology in malaria infections?
@ast
Is T-cell priming required for initiation of pathology in malaria infections?
@en
prefLabel
Is T-cell priming required for initiation of pathology in malaria infections?
@ast
Is T-cell priming required for initiation of pathology in malaria infections?
@en
P1433
P1476
Is T-cell priming required for initiation of pathology in malaria infections?
@en
P2093
P304
P356
10.1016/S0167-5699(99)01456-5
P577
1999-05-01T00:00:00Z